๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)
China flag China ยท Delayed Price ยท Currency is CNY
37.47
-0.68 (-1.78%)
Nov 20, 2026, 3:00 PM CST

SHA:600329 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4,6654,9177,3078,2228,2496,908
Revenue Growth
-13.05%-32.70%-11.13%-0.33%19.42%4.60%
Gross Profit
3,4243,6053,5033,5903,2582,747
Operating Income
1,058917.86774.04821.03671.32587.04
Net Income
895.672,1312,229986.71861.79769.14
Earnings Per Share
1.162.772.891.281.111.00
EPS Growth
-75.05%-4.15%125.78%15.32%11.00%16.28%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Chinese Medicine
4,2194,4615,6575,8365,6524,670
Western Medicine
85.8389.941,1921,6971,7831,596
Others
379.16366.23457.4673.08796.26626.9
Total
4,6654,9177,3078,2068,2316,892

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,7514,3323,9452,1872,9232,393
Total Debt
94.9175.6838.59339.14267.9143.17
Net Cash (Debt)
1,6564,2573,9061,8482,6552,350
Net Cash Growth
-3.37%8.98%111.39%-30.41%13.01%20.83%
Net Cash Per Share
2.155.535.062.403.423.05

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,248461.07924.67688.49677.25852.4
Capital Expenditures
-134.23-118.61-117.81-140.93-107.9-156.95
Free Cash Flow
1,114342.45806.86547.56569.34695.45
Free Cash Flow Growth
250.38%-57.56%47.36%-3.83%-18.13%44.21%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
73.39%73.31%47.94%43.66%39.49%39.77%
Operating Margin
22.68%18.67%10.59%9.98%8.14%8.50%
Pretax Margin
22.03%50.59%35.29%13.32%11.88%12.64%
Profit Margin
19.20%43.34%30.51%12.00%10.45%11.13%
FCF Margin
23.87%6.96%11.04%6.66%6.90%10.07%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
4.6804.7901.2801.2801.1200.500
Dividend Per Share Growth
274.22%274.22%0%14.29%124.00%66.67%
Dividend Yield
12.49%11.98%4.76%4.46%4.75%1.99%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
32.2414.449.2922.4221.1725.32
Forward PE
27.9624.6618.4020.0422.7322.87
P/FCF Ratio
22.0589.8825.6540.4032.0528.00
PS Ratio
5.266.262.832.692.212.82